VisionCare&#;s implantable telescope for end-stage AMD has finally been given FDA approval. The device, discussed in depth in Ophthalmology Times Europe July 2007, was given CE approval three years ago but has subsequently been undergoing rigorous clinical trials in the United States.
With automatic and non-contact measurement of the patient's eye, the new IOLMaster 500 offers the fastest and easiest way of calculating the right IOL for each patient.
In its continuing quest to play a part in every step of the cataract procedure Alcon is to acquire LenSx Lasers Inc., for $361.5 million in cash
As editor of Ophthalmology Times Europe I would like to hear your views about choices you make on behalf of your patients.
British and German scientists Dr Claus Cursiefen and his colleagues have reported that transplanted corneas are more likely to fail or be rejected in patients whose eyes exhibit abnormal vessel growth, called corneal neovascularization, before surgery.
Ophthalmic Women Leaders (OWL) and Women In Ophthalmology, Inc. (WIO) are pleased to announce their joint partnership in presenting the WIO Summer Symposium.
Just one of the themes delegates at this year's congress can explore.
For neovascular AMD sufferers, this combination therapy may offer an alternative to continual anti-VEGF injections
Applications in ophthalomology include gene delivery, cell delivery and nanosurgery.
Glaucoma is a final pathway of amny different disorders that can lead to a common pattern of optic nerve and visual field damage
Some of the products that company's will shoiwcase at this year's ESCRS.
12-month data from the BOLT study provides supporting evidence for the use of bevacizumab in patients with clinically significant DME.
An holistic approach that focuses on the healthy part of the cornea.
Innovative pharmacological approaches investigated in haze prevention research
Investigating the tolerability and IOP reduction effect of switching from latanoprost to tafluprost in patients exhibiting ocular surface side effects
At WOC 2010 there were 738 sessions and 1120 posters and over 13,000 people attended the Congress. OTEurope brings you a selection of Berlin highlights.
The French EyeOP1 medical device, from EyeTechCare, is a novel and non-invasive treatment for glaucoma that is based on the use of high-intensity focused ultrasound (HIFUs). The product is set to become available at the end of 2010
The merger Novartis has been trying to unilaterally impose on Alcon cannot go ahead without the approval of Alcon's Independent Director Committee (IDC), according to a legal expert
Ophthalmic instrument and replacement lens business, Ophtec BV, has expanded its business into the Far East with a site based in Japan.
Scientists in The Netherlands have received an innovation grant to finalise the specification of a collagen, derived from fishscale, which will act as an alternative material for cornea regeneration.
President of the Middle East African Council of Ophthalmology (MEACO), Dr Abdulaziz Al Rajhi, is to become president of the World Ophthalmology Congress (WOC) 2012.
Dr Joachim Storsberg at the Fraunhofer Institute for Applied Polymer Research in Germany has developed an artificial cornea. The ophthalmological polymer is designed to bond to the eye but remain unclouded by cells in its centre.
Alcon Inc. is to sponsor a four-week ophthalmic skills exchange and surgical programme through ORBIS International?s signature Flying Eye Hospital.
France Lens has launched, The Concept Asphilens 1.8, a new aspheric implant specifically designed for microincision cataract surgery (MICS).
As part of last week's National Eye Health Week in the UK, Spectrum Théa, the independent ophthalmic company, looked at things from a patient's perspective.
The Pediatric Cataract Initiative ( ), sponsored by the Bausch + Lomb Early Vision Institute and Lions Clubs International Foundation, has announced its inaugural global advisory council.
Fight for Sight, a UK leading eye research charity, has awarded two new grants totalling £350,000 for research into glaucoma ? one of the leading causes of preventable blindness in the UK
In a sample of moderate evaporative-type dry eye disease patients Enriquez-de-Salamanca et al., elevated five inflammatory molecules. Fracktalkine was demonstrated to be present and elevated in tears in human DED.
Imprinting tiny brand logos and providing miniaturized functional inscriptions on hard and transparent high value parts such as eye glass lenses and diamonds requires a material-friendly and high-resolution marking and engraving tool. The short 193nm pulses of excimer lasers eliminate the widely-known problems of cracking and melting which are due to thermal load effects of longer wavelength lasers. The low optical penetration depth of the 193nm wavelength in diamond, glass and plastic substrates prevents bulk heating and delivers cold and precise marks and engravings on a micron scale and in optically transparent material.
A new disinfecting technology for soft contact lenses from Abbott has received European regulatory approval. Complete RevitaLens Multipurpose Disinfecting Solution was developed in partnership with the Holden Vision Institute.